FSD Pharma Closes Deal to Acquire Prismic Pharmaceuticals

TORONTO – FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD Pharma” or the “Company”) and Prismic Pharmaceuticals Inc. (“Prismic”), a US-based specialty R&D pharmaceutical company (the “Parties”), announced today that, on June 28, 2019, they finalized the acquisition by FSD Pharma of all of the issued and outstanding securities of Prismic (the “Transaction”). […]

Go to Source
Author: Press Release
Puffin’ On Some Good New?! Share Some…

About admin